Role of specific protein binding motifs in TCDD-induced activation of the human polymorphic HS1,2 enhancer

WSU CORE Repository

 

Role of specific protein binding motifs in TCDD-induced activation of the human polymorphic HS1,2 enhancer

Show simple item record

dc.contributor Sulentic, Courtney
dc.contributor.author Ochs, Sharon
dc.coverage.temporal 2010 en_US
dc.date.accessioned 2011-06-20T14:45:23Z
dc.date.available 2011-06-20T14:45:23Z
dc.date.created 2010-04
dc.date.issued 2010-04
dc.identifier.other celebration_abstract10_ochs_s
dc.identifier.uri http://hdl.handle.net/2374.WSU/4773
dc.description.abstract

The immunoglobulin heavy chain (lgH) gene is transcriptionally regulated in part by the 3'lgH regulatory region (3'lgHRR) which is located downstream of the IgH locus and in humans consists of three enhancers (hs3; hsl,2; hs4). Utilizing a well-characterized mouse B-cell line (CH12.LX), our previous results have demonstrated a sensitive inhibition of the mouse 3'lgHRR by 2,3, 7, 8-tetrachlorodibenzor-dioxin (TCDDL a known disrupter of B-cell differentiation, which correlated well with TCDD-induced inhibition of IgH expression and Ig secretion. Interestingly, in humans a polymorphism of the hsl,2 enhancer (resulting in a varying number of tandem repeats of a 53 bp sequence) has been correlated with several autoimmune diseases. The human hsl,2 enhancer is also sensitive to TCDD-induced modulation but in contrast to the mouse hsl,2 and 3'lgHRR, TCDD activated the human hsl,2 enhancer perhaps through altered binding to one or more transcription factor binding sites within the hsl,2 enhancer (Le., ORE, kB, AP-l, Oct, SP1). The purpose of the current study was to elucidate the transcriptional regulation of the human polymorphic hsl,2 enhancer following TCDD induction. Utilizing site-directed mutagenesis, mutated luciferase reporter plasm ids were designed containing a variety of binding site deletions (ORE, Oct, 53bp, Oct+53bp). These plasm ids were transiently transfected into the CH12.LX cells then treated with TCDD in the absence or presence of lipopolysaccharide (LPS) stimulation. Deletion of the ORE site showed a modest increase in TCDD-induced activity; whereas deletion of both the Oct site and the 53bp repeat resulted in a complete loss of TCDD-induced activation. These results suggest that there is a concerted activation of the polymorphic hsl,2 enhancer involving Oct and a site within the 53 bp repeat that may be independent of the ORE. Studies are ongoing to evaluate the role of the AP-l site in relation to these effects. (Supported by NIEHS R01ES014676)

This presentation occurred at the Wright State University Campus-Wide Celebration of Research, Scholarship and Creative Activities on April 16, 2010

dc.language.iso en_US en_US
dc.publisher Wright State University en_US
dc.relation.ispartof Celebration of Research, Scholarship, and Creative Activities en_US
dc.rights.uri http://www.wright.edu/web/copyright.html
dc.subject Ochs, Sharon en_US
dc.subject Sulentic, Courtney en_US
dc.subject Wright State University. Boonshoft School of Medicine. Department of Pharmacology and Toxicology en_US
dc.title Role of specific protein binding motifs in TCDD-induced activation of the human polymorphic HS1,2 enhancer en_US
dc.type Presentation en_US
dc.permissions World
dc.publisher.digital Digital Services Department, Wright State University Libraries en_US
dc.date.digitized 2010-04
dc.publisher.OLinstitution Wright State University

Files in this item

Files Size Format View
celebration_abstract10_ochs_s.pdf 94.19Kb application/pdf Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search CORE


Advanced Search

Browse

My Account

About

Links